Unfortunately, current pharmacological interventions for AD-related memory impairment, such as cholinesterase inhibitors, offer limited benefit for memory loss [2,3]; this is also true of other interventions for AD such as lifestyle changes [4,5,6]. This evidence concerns the gene BCHE and Alzheimer disease.